4
Changes in Ownership
TransMedics Group, Inc. Filed Acc 0000899243-22-028141
Chief Commercial Officer sold 20,000 shares at an average $45.12 ($902,400)
- Chief Commercial Officer acquired 10,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Khayal Tamer I · Chief Commercial Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-08-05 | Exercise or conversion : show line 1 in the form | +10,000 | $2.21 | $22,100 | 11,300 | D |
| 2022-08-05 | Sale : show line 2 in the form | −10,000 | $45.16 | $451,600 | 1,300 | D |
| 2022-08-05 | Sale : show line 3 in the form | −10,000 | $45.08 | $450,800 | 34,776 | I |
| Open-market sales · 20,000 sh · avg $45.12 · $902,400 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-08-05 | Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) | −10,000 | 31,051 | D |
Loading xslF345X03/doc4.xml…